TILT Biotherapeutics
Helsinki, Finland · Founded 2013 · $38.9M raised
- Headquarters
- Helsinki
- Employees
- 11–50
- Founded
- 2013
- Business Model
- B2B
- Website
- tiltbio.com
- Total Funding
- $38.9M
- Last Round
- $25.6M Series BMay 2025
- Rounds
- 3
About
Develops cancer immunotherapies using engineered oncolytic adenoviruses to enhance T-cell responses.
Summary
TILT Biotherapeutics is a Biotech company based in Helsinki, Finland, founded in 2013. It has raised $38.9M in total across 3 rounds, most recently a $25.6M Series B round in May 2025. Investors include Lifeline Ventures, European Innovation Council Fund and Tesi.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
May 2025
Sign up to see all 3 rounds
Grant through Series B — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/tilt-biotherapeutics"><img src="https://indexed.vc/api/badge/company/tilt-biotherapeutics" alt="TILT Biotherapeutics on Indexed.vc" width="260" height="76" /></a>